Literature DB >> 28797928

Comparison of planar, PET and well-counter measurements of total tumor radioactivity in a mouse xenograft model.

Michael V Green1, Jurgen Seidel2, Mark R Williams2, Karen J Wong3, Anita Ton3, Falguni Basuli4, Peter L Choyke3, Elaine M Jagoda3.   

Abstract

INTRODUCTION: Quantitative small animal radionuclide imaging studies are often carried out with the intention of estimating the total radioactivity content of various tissues such as the radioactivity content of mouse xenograft tumors exposed to putative diagnostic or therapeutic agents. We show that for at least one specific application, positron projection imaging (PPI) and PET yield comparable estimates of absolute total tumor activity and that both of these estimates are highly correlated with direct well-counting of these same tumors. These findings further suggest that in this particular application, PPI is a far more efficient data acquisition and processing methodology than PET.
METHODS: Forty-one athymic mice were implanted with PC3 human prostate cancer cells transfected with prostate-specific membrane antigen (PSMA (+)) and one additional animal (for a total of 42) with a control blank vector (PSMA (-)). All animals were injected with [18F] DCFPyl, a ligand for PSMA, and imaged for total tumor radioactivity with PET and PPI. The tumors were then removed, assayed by well counting for total radioactivity and the values between these methods intercompared.
RESULTS: PET, PPI and well-counter estimates of total tumor radioactivity were highly correlated (R2>0.98) with regression line slopes near unity (0.95<slope≤1.02) and intercepts near zero (-0.001MBq≤intercept ≤0.004MBq).
CONCLUSION: Total mouse xenograft tumor radioactivity can be measured with PET or PPI with an accuracy comparable to well counting if certain experimental and pharmacokinetic conditions are met. In this particular application, PPI is significantly more efficient than PET in making these measurements.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer drug bio-distribution studies; Mouse tumor xenografts models; Quantitative PET; Quantitative planar imaging

Mesh:

Substances:

Year:  2017        PMID: 28797928      PMCID: PMC5610094          DOI: 10.1016/j.nucmedbio.2017.06.004

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  10 in total

1.  2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.

Authors:  Ying Chen; Mrudula Pullambhatla; Catherine A Foss; Youngjoo Byun; Sridhar Nimmagadda; Srinivasan Senthamizhchelvan; George Sgouros; Ronnie C Mease; Martin G Pomper
Journal:  Clin Cancer Res       Date:  2011-10-31       Impact factor: 12.531

2.  MONICA: a compact, portable dual gamma camera system for mouse whole-body imaging.

Authors:  Wenze Xi; Jurgen Seidel; John W Kakareka; Thomas J Pohida; Diane E Milenic; James Proffitt; Stan Majewski; Andrew G Weisenberger; Michael V Green; Peter L Choyke
Journal:  Nucl Med Biol       Date:  2010-04       Impact factor: 2.408

3.  Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate.

Authors:  Takahito Nakajima; Makoto Mitsunaga; Neil H Bander; Warren D Heston; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2011-07-27       Impact factor: 4.774

4.  Simultaneous ECG-gated PET imaging of multiple mice.

Authors:  Jurgen Seidel; Marcelino L Bernardo; Karen J Wong; Biying Xu; Mark R Williams; Frank Kuo; Elaine M Jagoda; Falguni Basuli; Changhui Li; Gary L Griffiths; Michael V Green; Peter L Choyke
Journal:  Nucl Med Biol       Date:  2014-03-29       Impact factor: 2.408

5.  Fast indirect fluorine-18 labeling of protein/peptide using the useful 6-fluoronicotinic acid-2,3,5,6-tetrafluorophenyl prosthetic group: A method comparable to direct fluorination.

Authors:  Falguni Basuli; Xiang Zhang; Carolyn C Woodroofe; Elaine M Jagoda; Peter L Choyke; Rolf E Swenson
Journal:  J Labelled Comp Radiopharm       Date:  2017-02-01       Impact factor: 1.921

6.  NEMA NU 4-2008 comparison of preclinical PET imaging systems.

Authors:  Andrew L Goertzen; Qinan Bao; Mélanie Bergeron; Eric Blankemeyer; Stephan Blinder; Mario Cañadas; Arion F Chatziioannou; Katherine Dinelle; Esmat Elhami; Hans-Sonke Jans; Eduardo Lage; Roger Lecomte; Vesna Sossi; Suleman Surti; Yuan-Chuan Tai; Juan José Vaquero; Esther Vicente; Darin A Williams; Richard Laforest
Journal:  J Nucl Med       Date:  2012-06-14       Impact factor: 10.057

7.  Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner.

Authors:  Yuchuan Wang; Jurgen Seidel; Benjamin M W Tsui; Juan J Vaquero; Martin G Pomper
Journal:  J Nucl Med       Date:  2006-11       Impact factor: 10.057

8.  Performance characteristics of a positron projection imager for mouse whole-body imaging.

Authors:  Jurgen Seidel; Wenze Xi; John W Kakareka; Thomas J Pohida; Elaine M Jagoda; Michael V Green; Peter L Choyke
Journal:  Nucl Med Biol       Date:  2013-02-09       Impact factor: 2.408

9.  Comparison of an 18F labeled derivative of vasoactive intestinal peptide and 2-deoxy-2-[18F]fluoro-D-glucose in nude mice bearing breast cancer xenografts.

Authors:  Elaine M Jagoda; Luigi Aloj; Jurgen Seidel; Lixin Lang; Terry W Moody; Shielah Green; Corradina Caraco; Margaret Daube-Witherspoon; Michael V Green; William C Eckelman
Journal:  Mol Imaging Biol       Date:  2002-10       Impact factor: 3.488

10.  Accurate molecular imaging of small animals taking into account animal models, handling, anaesthesia, quality control and imaging system performance.

Authors:  Christian Vanhove; Jens P Bankstahl; Stefanie D Krämer; Eric Visser; Nicola Belcari; Stefaan Vandenberghe
Journal:  EJNMMI Phys       Date:  2015-11-11
  10 in total
  1 in total

Review 1.  Advances in Preclinical PET.

Authors:  Stephen S Adler; Jurgen Seidel; Peter L Choyke
Journal:  Semin Nucl Med       Date:  2022-03-18       Impact factor: 4.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.